Das nanodiag BW Netzwerk
Die Überführung exzellenter Forschungsergebnisse in praktisch-wirtschaftlichen Nutzgewinn basiert auf Akteuren, die in der Lage sind, die Technologien zuzuliefern und anzupassen, welche typischerweise die Lücke zwischen wissenschaftlicher Erprobung und industrieller / klinisch-praktischer Anwendung schließen müssen. Dazu verknüpft der Zukunftscluster nanodiag BW multidisziplinäre Akteure aus Universitäten, Forschungseinrichtungen und Unternehmen entlang tiefer Wertschöpfungsketten, die von den naturwissenschaftlichen Grundlagen- und Materialwissenschaften über Nanotechnologie, Mikroelektronik und mikrofluidische Analytik bis zur klinischen Medizin reichen.
Das Netzwerk ist offen für Kooperationen und die Mitwirkung neuer Akteure!
Unternehmen
Unter den Cluster-Akteuren finden sich große Unternehmen und KMU, davon 7 Start-ups, mit Produkten und Dienstleistungen aus den Bereichen Nano- und Nanoporentechnologie, Mikroelektronik, Maschinelles Lernen, Bioinformatik, Bioanalytik, Epigenetik sowie molekulare und medizinische Diagnostik.
Actome GmbH
Actome will develop innovative PICO reference assays for the quantitative analysis of post-translational modifications (PTM) and protein-protein interactions (PPI). Actome also acts as a technology supplier and commerscializer in the project.
Aixtron SE
AIXTRON will work on the scientific aspects and the special requirements of epitaxy (in this case MOCVD) of sophisticated transition metal based structures (TMD) for applications in nanopore technology for molecular diagnostics.
AMO gGmbH
AMO contributes expertise in the synthesis, transfer and nanostructuring of 2D materials, in particular graphene and transition metal dichalcogenides (TMDCs) and adapts the related manufacturing techniques for the application in a solid-state nanoporeanalyzer.
Computomics
EpiQMax GmbH
Based on mass spectrometry technology, EpiQMAx has been analyzing post-translational modifications of proteins since 2018. We will actively contribute this know-how together with further developments in the field of automated sample preparation and the application area of epigenetics.
Eurofins Genomics GmbH
Eurofins Genomics will contribute to assay development of basic microfluidic operations, as well as the development and validation of an automated high-throughput reference workflow for very small sample volumes.
Ionera GmbH
The focus of Ionera's work is on the one hand the realization of an experimental environment for the characterization of biomimetic membranes and on the other hand the realization of a chip function pattern for the automated reconstitution of individual biological nanopores. AlsoIonera will work on the modification of solid-state nanopores, especially with regard to wettability (design of a measurement cartridge and the integration of powerful redox electrodes).
Nanion GmbH
Nanion develops and produces analysis systems for ion channels and biological nanopores. Microstructured chip substrates are used for electrophysiological measurements. AlsoNanion contributes expertise with regard to electrical measurement technology for nanopores and will also contribute to the fluidic and electrical integration of nanopores in diagnostic systems.
NanoTemper GmbH
Nanotemper Technologies will develop technologies and workflows to screen mutants of Aerolysin and will use the advanced biophysics instrumentation to characterise both the biophysical and biochemical properties of the resultant mutants.
Q-Bios GmbH
Entwicklung von DNA-Polymerasen, Enzymen und Reaktionsbedingungen für isothermale Nachweisreaktionen unter Hochsalz-Bedingungen im Rahmen der Nanoporen-Analytik.
Robert Bosch GmbH
Scinomics GmbH
Signatope GmbH
Steinbeis GmbH + Co.KG
The Steinbeis Europa Zentrum coordinates the continuation of the joint cluster and R&D strategy with the overall objective to focus the scientific and technological developments and to accelerate the innovation process.
Temicon GmbH
Temicon is developing new manufacturing methods for picoliter well arrays and uses the resulting microfluidic chips to explore electrical contacting of the novel well arrays.
TrenZyme GmbH
Forschungseinrichtungen
Zwischen den Forschungspartnern des Clusters bestehen bereits zahlreiche erfolgreich etablierte Kooperationen; die Institute der Innovationsallianz Baden-Württemberg (innBW) Hahn-Schickard, ILM und NMI bilden die Brücke zwischen Grundlagenforschung und Industrie/ Klinik.
Fraunhofer-Institut für Werkstoffmechanik IWM, Freiburg
Goethe-Universität Frankfurt am Main
General information about this institution:
The work of the group pf Prof. Schiller focuses on the development & (bio)synthesis of complex, amphiphilic molecular systems for adaptive membrane architectures that allow the selective reconstitution and sensitive analysis of biological nanopores.
Hahn-Schickard, Freiburg und Villingen-Schwenningen
ILM Institut für Lasertechnologien in der Medizin und Meßtechnik an der Universität Ulm
The ILM is investigating the fabrication of laser-induced solid-state nanopores. After analyzing the requirements, the process will be established and further developed with the help of a modular confocal microscope setup to be implemented. The characterized solid-state nanoporeswill then be made available to the project partners.
NMI, Naturwissenschaftlichs und Medizinisches Institut Reutlingen
Jannik Meyer's "Advanced Materials" research group will explore the targeted insertion of nanopores into 2D materials and other membrane materials and investigate the structure of the membranes and pores using atomic-resolution electron microscopy.
Peter Jones's research group fabricates solid-state nanopores using focused electron or ion beams and also integrate them in arrays with microfluidics and electrodes. The expertise includes low-noise ionic current measurements at high-bandwidths, and characterization of nanopores' structure and chemistry at the atomic scale using (S)TEM, EDX, and EELS.
Max-Planck-Institut für Immunbiologie und Epigenetik (MPI-IE), Freiburg
Affinity methods are to be developed which provide peptides carrying specific sequence variations or modifications .This will allowto isolate individual peptides or peptide families from highly complex mixtures (biological and clinical samples) and make them accessible for bionanopore analysis.
Universität Freiburg
General information about this partner:
The group of Professor Krossing provides weakly coordinating anions adjustable in size as “molecular rulers” for the determination of pore sizes.
Universitätsklinikum Freiburg
General information about this partner institution:
https://www.uniklinik-freiburg.de/medizin1.html
The group of Prof. Dr. Heiko Becker aims to use recently developed innovative analytical methods to identify novel epigenetic biomarkers for precision oncology and establish them as part of personalized medicine in the long term.
Universität Stuttgart
The group of Prof. Holm develops in collaboration with Prof. Fyta (RWTH Aachen University) a software framework using machine learning methods to enable fast and reliable recognition of protein sequences.
Also atomistic MD simulations are performed to resolve microscale processes of protein translocation within aerolys in nanopores using a multiscale simulation approach together with Prof. Walter (Freiburg).
The research group of Prof. Nussberger is investigating the assembly kinetics of different biological nanopore variants and the development of methods for inserting individual nanochannels into membranes for nanopore sensing. Methodologically, the aim is to visualize the assembly and integration process in artificial lipid membranes optically at the single molecule level.
